• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在早期未接受治疗的帕金森病患者中,排尿功能障碍与黑质纹状体多巴胺能神经元退变有关。

Urinary Dysfunction Is Associated with Nigrostriatal Dopaminergic Degeneration in Early and Untreated Patients with Parkinson's Disease.

作者信息

Wang Jing, Cao Ruihua, Huang Tao, Liu Cheng, Fan Yidong

机构信息

Department of Urology, Qilu Hospital, Cheeloo College of Meicine, Shandong University, Jinan, China.

Department of Urologic Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.

出版信息

Parkinsons Dis. 2020 Nov 28;2020:4981647. doi: 10.1155/2020/4981647. eCollection 2020.

DOI:10.1155/2020/4981647
PMID:33354313
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7737470/
Abstract

The aim of the present study was to determine the relation between urinary dysfunction and nigrostriatal dopaminergic degeneration in early and untreated Parkinson's disease (PD). The data were obtained from Parkinson's Progression Markers Initiative database. Two hundred and seventy-five patients and 149 healthy controls were included in our analysis. Urinary symptoms were evaluated with the Scale for Outcomes in Parkinson's Disease for Autonomic Symptoms (SCOPA-AUT). We performed correlation analyses between I-FP-CIT SPECT imaging data and severity of urinary symptoms in patients with PD and healthy controls. Early and untreated patients with PD exhibited worse urinary symptoms when compared with healthy controls. The severity of urinary symptoms significantly correlated with dopamine transporter binding levels in the caudate and the putamen. After controlling for age and sex, the severity of storage symptoms significantly correlated with dopamine transporter binding levels in the less affected side of the putamen ( = -0.172, =0.004). The correlation was observed in both male ( = -0.152, =0.043) and female patients ( = -0.217, =0.034). No correlations were found between dopamine transporter binding levels and voiding symptoms in male or female patients, or any urinary symptoms in healthy controls. Worse storage symptoms reflect greater nigrostriatal dopaminergic loss in early and untreated PD.

摘要

本研究的目的是确定早期未经治疗的帕金森病(PD)患者的排尿功能障碍与黑质纹状体多巴胺能变性之间的关系。数据来自帕金森病进展标志物倡议数据库。我们的分析纳入了275例患者和149名健康对照。使用帕金森病自主神经症状结局量表(SCOPA-AUT)评估排尿症状。我们对PD患者和健康对照的I-FP-CIT SPECT成像数据与排尿症状严重程度进行了相关性分析。与健康对照相比,早期未经治疗的PD患者表现出更严重的排尿症状。排尿症状的严重程度与尾状核和壳核中的多巴胺转运体结合水平显著相关。在控制年龄和性别后,储尿症状的严重程度与壳核受累较轻一侧的多巴胺转运体结合水平显著相关(r = -0.172,P = 0.004)。在男性(r = -0.152,P = 0.043)和女性患者(r = -0.217,P = 0.034)中均观察到这种相关性。在男性或女性患者中,未发现多巴胺转运体结合水平与排尿症状之间存在相关性,在健康对照中也未发现与任何排尿症状存在相关性。更严重的储尿症状反映了早期未经治疗的PD患者黑质纹状体多巴胺能损失更大。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/388c/7737470/6d20e63515df/PD2020-4981647.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/388c/7737470/6d20e63515df/PD2020-4981647.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/388c/7737470/6d20e63515df/PD2020-4981647.001.jpg

相似文献

1
Urinary Dysfunction Is Associated with Nigrostriatal Dopaminergic Degeneration in Early and Untreated Patients with Parkinson's Disease.在早期未接受治疗的帕金森病患者中,排尿功能障碍与黑质纹状体多巴胺能神经元退变有关。
Parkinsons Dis. 2020 Nov 28;2020:4981647. doi: 10.1155/2020/4981647. eCollection 2020.
2
SPECT imaging of the dopamine transporter with [(123)I]-beta-CIT reveals marked decline of nigrostriatal dopaminergic function in Parkinson's disease with urinary dysfunction.使用[(123)I]-β-CIT对多巴胺转运体进行单光子发射计算机断层扫描成像显示,帕金森病合并排尿功能障碍患者黑质纹状体多巴胺能功能显著下降。
J Neurol Sci. 2001 Jun 15;187(1-2):55-9. doi: 10.1016/s0022-510x(01)00521-4.
3
An FP-CIT PET comparison of the difference in dopaminergic neuronal loss in subtypes of early Parkinson's disease.早期帕金森病各亚型多巴胺能神经元丢失差异的氟代脱氧苯丙氨酸-碳-11标记的N-甲基-4-苯基-1,2,3,6-四氢吡啶正电子发射断层扫描比较
Acta Radiol. 2014 Apr;55(3):366-71. doi: 10.1177/0284185113498075. Epub 2013 Aug 13.
4
Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study.特发性快速眼动睡眠行为障碍患者黑质纹状体功能的连续多巴胺转运体成像:一项前瞻性研究。
Lancet Neurol. 2011 Sep;10(9):797-805. doi: 10.1016/S1474-4422(11)70152-1. Epub 2011 Jul 28.
5
The longitudinal progression of autonomic dysfunction in Parkinson's disease: A 7-year study.帕金森病自主神经功能障碍的纵向进展:一项7年研究。
Front Neurol. 2023 Apr 12;14:1155669. doi: 10.3389/fneur.2023.1155669. eCollection 2023.
6
123I-FP-CIT semi-quantitative SPECT detects preclinical bilateral dopaminergic deficit in early Parkinson's disease with unilateral symptoms.123I - FP - CIT半定量单光子发射计算机断层扫描(SPECT)可检测出有单侧症状的早期帕金森病患者临床上未出现的双侧多巴胺能缺陷。
Nucl Med Commun. 2005 May;26(5):421-6. doi: 10.1097/00006231-200505000-00005.
7
Extrastriatal I-FP-CIT SPECT impairment in Parkinson's disease - the PPMI cohort.帕金森病患者纹状体外 I-FP-CIT SPECT 损伤 - PPMI 队列。
BMC Neurol. 2020 May 16;20(1):192. doi: 10.1186/s12883-020-01777-2.
8
Urological dysfunctions in patients with Parkinson's disease: clues from clinical and non-invasive urological assessment.帕金森病患者的泌尿系统功能障碍:来自临床和非侵入性泌尿系统评估的线索
BMC Neurol. 2018 Sep 20;18(1):148. doi: 10.1186/s12883-018-1151-z.
9
[123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease.[123I]FP - CIT单光子发射计算机断层扫描显示,在早期和晚期帕金森病中,纹状体多巴胺转运体标记明显减少。
J Neurol Neurosurg Psychiatry. 1997 Feb;62(2):133-40. doi: 10.1136/jnnp.62.2.133.
10
Cognitive executive impairment and dopaminergic deficits in de novo Parkinson's disease.新发帕金森病的认知执行功能障碍与多巴胺能缺陷
Mov Disord. 2014 Dec;29(14):1802-8. doi: 10.1002/mds.26051. Epub 2014 Oct 4.

引用本文的文献

1
Motor and Non-motor Neurologic Symptoms of Wilson's Disease: Exploring the Associations.威尔逊病的运动和非运动神经症状:探索其关联
Ann Indian Acad Neurol. 2025 Jan 1;28(1):66-71. doi: 10.4103/aian.aian_503_24. Epub 2025 Feb 6.
2
Urodynamic study and its correlation with cardiac meta-iodobenzylguanidine (MIBG) in body-first and brain-first subtypes of Parkinson's disease.尿动力学研究及其与帕金森病体首型和脑首型亚型心脏间碘苄胍(MIBG)的相关性。
Eur J Neurol. 2024 Dec;31(12):e16497. doi: 10.1111/ene.16497. Epub 2024 Sep 30.
3
Urinary extracellular vesicle dynamics in Parkinson's disease patients with urinary dysfunction.

本文引用的文献

1
Aquaporin 4: A key player in Parkinson's disease.水通道蛋白 4:帕金森病的关键因素。
J Cell Physiol. 2019 Dec;234(12):21471-21478. doi: 10.1002/jcp.28871. Epub 2019 May 24.
2
Correlation of serum levels and gene expression of tumor necrosis factor-α-induced protein-8 like-2 with Parkinson disease severity.肿瘤坏死因子-α诱导蛋白 8 样-2 血清水平与基因表达与帕金森病严重程度的相关性。
Metab Brain Dis. 2018 Dec;33(6):1955-1959. doi: 10.1007/s11011-018-0302-7. Epub 2018 Aug 13.
3
Increased odds of bladder and bowel symptoms in early Parkinson's disease.
帕金森病伴排尿功能障碍患者的尿细胞外囊泡动态变化
Front Neurol. 2023 Nov 17;14:1250832. doi: 10.3389/fneur.2023.1250832. eCollection 2023.
4
Pattern of prefrontal cortical activation and network revealed by task-based and resting-state fNIRS in Parkinson's disease's patients with overactive bladder symptoms.基于任务和静息态功能近红外光谱技术揭示帕金森病伴膀胱过度活动症患者的前额叶皮质激活模式及网络
Front Neurosci. 2023 Mar 30;17:1142741. doi: 10.3389/fnins.2023.1142741. eCollection 2023.
5
Role of Urological Botulinum Toxin-A Injection for Overactive Bladder and Voiding Dysfunction in Patients with Parkinson's Disease or Post-Stroke.尿失禁和排尿功能障碍在帕金森病或脑卒中患者中的作用:泌尿科肉毒杆菌毒素 A 注射治疗。
Toxins (Basel). 2023 Feb 17;15(2):166. doi: 10.3390/toxins15020166.
6
Toxin Induced Parkinsonism and Hospitalization Related Adverse Outcome Mitigation for Parkinson's Disease: A Comprehensive Review.毒素诱发的帕金森病及帕金森病住院相关不良结局的缓解:一项综合综述
J Clin Med. 2023 Jan 30;12(3):1074. doi: 10.3390/jcm12031074.
7
Association between Parkinson's Disease Medication and the Risk of Lower Urinary Tract Infection (LUTI): A Retrospective Cohort Study.帕金森病药物与下尿路感染风险之间的关联:一项回顾性队列研究。
J Clin Med. 2022 Nov 29;11(23):7077. doi: 10.3390/jcm11237077.
8
Urinary Tract Infection in Parkinson's Disease.帕金森病患者的尿路感染。
J Parkinsons Dis. 2022;12(3):743-757. doi: 10.3233/JPD-213103.
9
Dopamine Transporter Imaging, Current Status of a Potential Biomarker: A Comprehensive Review.多巴胺转运体显像:一个潜在生物标志物的现状综述。
Int J Mol Sci. 2021 Oct 18;22(20):11234. doi: 10.3390/ijms222011234.
早期帕金森病患者出现膀胱和肠道症状的几率增加。
Neurourol Urodyn. 2018 Apr;37(4):1344-1348. doi: 10.1002/nau.23443. Epub 2017 Nov 2.
4
Constipation is not associated with dopamine transporter pathology in early drug-naïve patients with Parkinson's disease.便秘与早期未经药物治疗的帕金森病患者的多巴胺转运体病理无关。
Eur J Neurol. 2018 Feb;25(2):307-312. doi: 10.1111/ene.13503. Epub 2017 Dec 11.
5
Benign prostatic hyperplasia.良性前列腺增生症。
Nat Rev Dis Primers. 2016 May 5;2:16031. doi: 10.1038/nrdp.2016.31.
6
Effects of aging and gender on striatal and extrastriatal [123I]FP-CIT binding in Parkinson's disease.衰老和性别对帕金森病纹状体及纹状体以外区域[123I]FP-CIT结合的影响。
Neurobiol Aging. 2015 Apr;36(4):1757-1763. doi: 10.1016/j.neurobiolaging.2015.01.016. Epub 2015 Jan 22.
7
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease.初发帕金森病患者左旋多巴需求量的非运动预测因素
Mov Disord. 2015 Mar;30(3):373-8. doi: 10.1002/mds.26076. Epub 2015 Feb 4.
8
Bladder function of patients with Parkinson's disease.帕金森病患者的膀胱功能
Int J Urol. 2014 Jul;21(7):638-46. doi: 10.1111/iju.12421. Epub 2014 Feb 27.
9
The Parkinson Progression Marker Initiative (PPMI).帕金森进展标志物倡议(PPMI)。
Prog Neurobiol. 2011 Dec;95(4):629-35. doi: 10.1016/j.pneurobio.2011.09.005. Epub 2011 Sep 14.
10
Urinary dysfunction in early and untreated Parkinson's disease.早期未经治疗的帕金森病患者的尿功能障碍。
J Neurol Neurosurg Psychiatry. 2011 Dec;82(12):1382-6. doi: 10.1136/jnnp.2011.241075. Epub 2011 Jun 13.